Challenges Before Considering to Monitor Patients With cTnT as Identification Tool for High Mortality Risk

Basit Öğe Kaydı
dc.contributor.authorAğırbaşlı, Mehmet
dc.date.accessioned2025-05-10T19:50:01Z
dc.date.issued2022
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstract[No abstract available]
dc.identifier.doi10.1016/j.jacc.2022.02.043
dc.identifier.issn0735-1097
dc.identifier.issn1558-3597
dc.identifier.issue18
dc.identifier.pmid35512869
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1016/j.jacc.2022.02.043
dc.identifier.urihttps://hdl.handle.net/20.500.14730/12210
dc.identifier.volume79
dc.identifier.wosWOS:000806252600001
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.institutionauthorAğırbaşlı, Mehmet
dc.language.isoen
dc.publisherElsevier Science Inc
dc.relation.ispartofJournal of The American College of Cardiology
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250302
dc.titleChallenges Before Considering to Monitor Patients With cTnT as Identification Tool for High Mortality Risk
dc.typeLetter

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
12210.pdf
Boyut:
58.81 KB
Biçim:
Adobe Portable Document Format
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu